Test Objectives
- Monitor patient response to pancreatic cancer treatment.
- Detect potential cancer recurrence after therapy.
- Assist in evaluating bile duct obstructions or inflammation.
Book CA 19-9 Test in Saudi Arabia | Lahalak Medical Platform
The CA 19-9 test is a vital tool for monitoring pancreatic cancer treatment effectiveness and disease progression, providing you with accurate insights into your therapeutic journey and peace of mind during recovery.
Scientific name: Cancer Antigen 19-9 (CA 19-9) Test
A laboratory blood test measuring CA 19-9 protein levels. It is primarily used to monitor pancreatic cancer patients' response to chemotherapy or surgery and track potential recurrence or disease progression.
Service type
Laboratory test
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Blood sample collection
- Laboratory analysis
- Electronic result delivery
Medical Service Information
Target Groups
- Individuals previously diagnosed with pancreatic cancer.
- Patients undergoing chemotherapy or radiation for oncology.
- Patients with chronic gallbladder or bile duct issues.
Frequently Asked Questions
- Does a high level always mean cancer? No, it can rise in benign conditions like pancreatitis.
- When will results be ready? Usually within 24 to 48 hours.
Conditions & Notices
- Inform the doctor about any medications
- No prior fasting is required
Medical services you might also like
